Telesis Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.14 | -$4.14 | -$4.14 |
| Q2 2024 | 1 | -$4.03 | -$4.03 | -$4.03 |
| Q3 2024 | 1 | -$5.30 | -$5.30 | -$5.30 |
| Q4 2024 | 1 | -$5.03 | -$5.03 | -$5.03 |
Telesis Bio, Inc. Earnings Date And Information
Telesis Bio, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-3.83 earnings per share for the quarter, topping analysts' consensus estimates of $-6.58 by $2.75. The company had revenue of 1.55 M for the quarter and had revenue of 27.51 M for the year. Telesis Bio, Inc. has generated $-2 earnings per share over the last year ($-29.56 diluted earnings per share) and currently has a price-to-earnings ratio of -0.03. Telesis Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Telesis Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | -$7.62 | $6.50 M | $1.55 M | ||
| 03/29/2024 | Q1 2024 | -$0.29 | $3.44 M | |||
| 12/29/2023 | Q4 2023 | -$0.59 | $6.98 M | |||
| 09/29/2023 | Q3 2023 | -$0.35 | $7.40 M | $5.56 M | ||
| 06/30/2023 | Q2 2023 | -$0.28 | $8.60 M | $8.65 M | ||
| 03/31/2023 | Q1 2023 | -$0.37 | $6.32 M | |||
| 12/31/2022 | Q4 2022 | -$0.28 | $9.47 M | |||
| 09/29/2022 | Q3 2022 | -$0.42 | $5.30 M | $6.68 M | ||
| 06/30/2022 | Q2 2022 | -$0.50 | $4.60 M | $5.66 M | ||
| 03/31/2022 | Q1 2022 | -$0.45 | $5.64 M | |||
| 12/31/2021 | Q4 2021 | -$0.43 | $3.08 M | |||
| 09/30/2021 | Q3 2021 | -$0.34 | $2.93 M | $2.79 M | ||
| 08/05/2021 | Q2 2021 | -$0.32 | $2.53 M | $2.85 M | ||
| 05/06/2021 | Q1 2021 | -$0.26 | $2.33 M | |||
| 03/01/2021 | Q4 2020 | -$0.22 | $1.94 M | |||
| 11/05/2020 | Q3 2020 | $0.20 | -$0.21 | -0.41 | $1.64 M | |
| 08/06/2020 | Q2 2020 | -$0.43 | -$0.19 | 0.24 | $1.62 M | |
| 05/07/2020 | Q1 2020 | -$0.46 | -$0.18 | 0.28 | $1.39 M | |
| 03/12/2020 | Q4 2019 | -$0.42 | -$0.52 | -0.1 | $3.89 M | |
| 11/06/2019 | Q3 2019 | -$0.46 | -$0.41 | 0.05 | $1.27 M |
Telesis Bio, Inc. Earnings: Frequently Asked Questions
-
When is Telesis Bio, Inc.'s earnings date?
Telesis Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Telesis Bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, Telesis Bio, Inc. (:TBIO) reported $-3.83 earnings per share (EPS) to beat the analysts' consensus estimate of $-6.58 by $2.75.
-
How can I listen to Telesis Bio, Inc.'s earnings conference call?
The conference call for Telesis Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Telesis Bio, Inc.'s conference call transcript?
The conference call transcript for Telesis Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does Telesis Bio, Inc. generate each year?
Telesis Bio, Inc. (:TBIO) has a recorded annual revenue of $27.51 M.
-
How much profit does Telesis Bio, Inc. generate each year?
Telesis Bio, Inc. (:TBIO) has a recorded net income of $27.51 M. Telesis Bio, Inc. has generated $-1.64 earnings per share over the last four quarters.
-
What is Telesis Bio, Inc.'s price-to-earnings ratio?
Telesis Bio, Inc. (:TBIO) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is 0.
